• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期复发性心肌梗死的临床特征。

Clinical features of early recurrent myocardial infarction.

作者信息

Sakakura Kenichi, Kubo Norifumi, Ako Junya, Ikeda Nahoko, Funayama Hiroshi, Hirahara Taishi, Wada Hiroshi, Sugawara Yoshitaka, Yasu Takanori, Kawakami Masanobu, Momomura Shin-ichi

机构信息

Division of Cardiovascular Medicine, Department of Integrated Medicine I, Jichi Medical University Saitama Medical Center, Omiya, Saitama, Japan.

出版信息

Heart Vessels. 2009 Sep;24(5):347-51. doi: 10.1007/s00380-008-1133-y. Epub 2009 Sep 27.

DOI:10.1007/s00380-008-1133-y
PMID:19784817
Abstract

Recurrence of myocardial infarction, especially when occurring early after the prior one, carries a significant morbidity and mortality rate. The aim of this study was to investigate the characteristics of patients who experienced recurrence under secondary prevention therapy. Case record review identified myocardial infarction patients who had a history of previous myocardial infarction within 5 years. Hospital chart records, initial laboratory data, medications, and type of infarction were reviewed. Patients were divided into two groups according to the interval of recurrence: an early group (recurrence within 1 year), and a late group (recurrence after more than 1 year). A total of 89 patients were included in the analysis; 40 patients in the early group, and 49 patients in the late group. Mean age in the early group and late groups was 67.3 +/- 11.9 and 59.4 +/- 8.9, respectively (P = 0.001). Mean body mass index in the early and late groups was 22.1 +/- 3.6 and 25.0 +/- 3.3, respectively (P < 0.001). There were fewer current smokers in the early group (7.5% vs 44.9%, P < 0.001) and more stent thrombosis (17.5% vs 2%, P = 0.02), as compared with the late group. The in-hospital mortality rate tended to be higher in the early group (7.5% vs 0%, P = 0.09). Multiple logistic regression revealed that smoking status (odds ratio [OR] 0.09, 95% confidence interval [CI] 0.02-0.49, P = 0.005), HDL cholesterol level (5 mg/dl increase: OR 1.34, 95% CI 1.04-1.74, P = 0.03), and stent thrombosis (OR 35.59, 95% CI 2.13-595.49, P = 0.01) had significant associations with early recurrence. Early recurrence of myocardial infarction was associated with stent thrombosis, a higher HDL cholesterol level, and a lower frequency of smoking. Early recurrence had a trend toward higher mortality than late recurrence.

摘要

心肌梗死复发,尤其是在前次心肌梗死后不久发生时,具有显著的发病率和死亡率。本研究的目的是调查在二级预防治疗下经历复发的患者的特征。病例记录回顾确定了在5年内有过心肌梗死病史的心肌梗死患者。回顾了医院病历记录、初始实验室数据、用药情况和梗死类型。根据复发间隔将患者分为两组:早期组(1年内复发)和晚期组(1年后复发)。共有89例患者纳入分析;早期组40例,晚期组49例。早期组和晚期组的平均年龄分别为67.3±11.9岁和59.4±8.9岁(P = 0.001)。早期组和晚期组的平均体重指数分别为22.1±3.6和25.0±3.3(P < 0.001)。与晚期组相比,早期组当前吸烟者较少(7.5%对44.9%,P < 0.001),支架血栓形成较多(17.5%对2%,P = 0.02)。早期组的院内死亡率有更高的趋势(7.5%对0%,P = 0.09)。多因素逻辑回归显示,吸烟状况(比值比[OR]0.09,95%置信区间[CI]0.02 - 0.49,P = 0.005)、高密度脂蛋白胆固醇水平(每增加5mg/dl:OR 1.34,95%CI 1.04 - 1.74,P = 0.03)和支架血栓形成(OR 35.59,95%CI 2.13 - 595.49,P = 0.01)与早期复发有显著关联。心肌梗死早期复发与支架血栓形成、较高的高密度脂蛋白胆固醇水平和较低的吸烟频率有关。早期复发的死亡率有高于晚期复发的趋势。

相似文献

1
Clinical features of early recurrent myocardial infarction.早期复发性心肌梗死的临床特征。
Heart Vessels. 2009 Sep;24(5):347-51. doi: 10.1007/s00380-008-1133-y. Epub 2009 Sep 27.
2
Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction.含屈螺酮的口服避孕药与心肌梗死后不良结局的风险。
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):387-93. doi: 10.1002/ccd.24839. Epub 2013 Mar 2.
3
Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry.ST 段抬高型心肌梗死合并多支血管病变患者梗死相关动脉与多血管血运重建的比较:来自韩国急性心肌梗死注册登记研究的分析。
Cardiol J. 2012;19(3):256-66. doi: 10.5603/cj.2012.0047.
4
Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).晚期和极晚期药物洗脱支架血栓形成的相关因素和结果:DESERT(国际药物洗脱支架血栓形成事件注册研究)的结果。
JACC Cardiovasc Interv. 2014 Oct;7(10):1093-102. doi: 10.1016/j.jcin.2014.04.017. Epub 2014 Sep 17.
5
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.随机比较依维莫司洗脱支架和西罗莫司洗脱支架在 ST 段抬高型心肌梗死患者中的应用:RACES-MI 试验。
JACC Cardiovasc Interv. 2014 Aug;7(8):849-56. doi: 10.1016/j.jcin.2014.02.016.
6
Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction: a propensity score-matched analysis.急性心肌梗死患者中使用 2 种新一代药物洗脱支架的无限制应用:倾向评分匹配分析。
JACC Cardiovasc Interv. 2012 Sep;5(9):936-45. doi: 10.1016/j.jcin.2012.05.009.
7
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).药物洗脱支架与金属裸支架置入治疗 ST 段抬高型心肌梗死患者的长期疗效:DEDICATION 试验(急性心肌梗死中药物洗脱和远端保护)的 5 年随访结果
JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15.
8
Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.单纯支架置入术与辅助球囊血管成形术治疗隐静脉桥血管经皮冠状动脉介入治疗:来自 DIVA 试验的见解。
Circ Cardiovasc Interv. 2020 Feb;13(2):e008494. doi: 10.1161/CIRCINTERVENTIONS.119.008494. Epub 2020 Feb 5.
9
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).生物可吸收血管支架与依维莫司洗脱金属支架治疗 ST 段抬高型心肌梗死:倾向评分匹配比较的 1 年结果:BVS-EXAMINATION 研究(生物可吸收血管支架——依维莫司洗脱冠状动脉支架治疗 ST 段抬高型心肌梗死患者的临床评估)。
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-197. doi: 10.1016/j.jcin.2014.10.005.
10
Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART).比较雷帕霉素洗脱支架早期、晚期和极晚期支架血栓形成患者的基线人口统计学、临床表现和长期预后:来自支架血栓形成注册研究的观察结果,用于审查和再评估(RESTART)。
Circulation. 2010 Jul 6;122(1):52-61. doi: 10.1161/CIRCULATIONAHA.109.903955. Epub 2010 Jun 21.

引用本文的文献

1
Comparison of the pathways of care and life courses between first-time ST-elevation myocardial infarction (STEMI) and STEMI with prior MI: findings from the OSCAR registry.首次 ST 段抬高型心肌梗死(STEMI)与有既往 MI 的 STEMI 患者之间的治疗途径和生命历程比较:来自 OSCAR 登记研究的结果。
BMJ Open. 2020 Nov 5;10(11):e038773. doi: 10.1136/bmjopen-2020-038773.
2
A case of subacute thrombosis associated with clopidogrel resistance after implantation of a zotarolimus-eluting stent.一例佐他莫司洗脱支架植入术后与氯吡格雷抵抗相关的亚急性血栓形成病例。
Heart Vessels. 2012 Jan;27(1):106-9. doi: 10.1007/s00380-011-0134-4. Epub 2011 Mar 29.
3

本文引用的文献

1
Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.心肌梗死后使用不同β受体阻滞剂进行二级预防的患者的死亡率和再梗死情况。
Cardiology. 2009;112(2):144-50. doi: 10.1159/000143389. Epub 2008 Jul 9.
2
Prognostic significance of multiple-detector computed tomography in conjunction with TIMI risk score for patients with non-ST elevation acute coronary syndrome.多排螺旋CT联合TIMI风险评分对非ST段抬高型急性冠状动脉综合征患者的预后意义
Heart Vessels. 2008 May;23(3):161-6. doi: 10.1007/s00380-007-1025-6. Epub 2008 May 17.
3
Influence of diabetes on >10-year outcomes after percutaneous coronary intervention.
Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up).
急性心肌梗死发生时较高的体重指数与良好的长期预后(8年随访)相关。
Heart Vessels. 2011 Sep;26(5):495-501. doi: 10.1007/s00380-010-0083-3. Epub 2011 Jan 7.
糖尿病对经皮冠状动脉介入治疗后10年以上预后的影响。
Heart Vessels. 2008 May;23(3):149-54. doi: 10.1007/s00380-007-1021-x. Epub 2008 May 17.
4
Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events.异常的CD4+CD28阴性T淋巴细胞与急性冠脉事件复发
J Am Coll Cardiol. 2007 Oct 9;50(15):1450-8. doi: 10.1016/j.jacc.2007.06.040. Epub 2007 Sep 24.
5
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.药物洗脱支架和裸金属支架相关的结局:一项协作网络荟萃分析。
Lancet. 2007 Sep 15;370(9591):937-48. doi: 10.1016/S0140-6736(07)61444-5.
6
Endothelial dysfunction, intima-media thickness, ankle-brachial pressure index, and pulse pressure in young post-myocardial infarction patients with various expressions of classical risk factors.患有不同经典危险因素表现的年轻心肌梗死后患者的内皮功能障碍、内膜中层厚度、踝臂指数和脉压。
Heart Vessels. 2007 Jul;22(4):215-22. doi: 10.1007/s00380-006-0958-5. Epub 2007 Jul 20.
7
Clinical end points in coronary stent trials: a case for standardized definitions.冠状动脉支架试验中的临床终点:标准化定义的必要性
Circulation. 2007 May 1;115(17):2344-51. doi: 10.1161/CIRCULATIONAHA.106.685313.
8
Stent thrombosis in randomized clinical trials of drug-eluting stents.药物洗脱支架随机临床试验中的支架内血栓形成
N Engl J Med. 2007 Mar 8;356(10):1020-9. doi: 10.1056/NEJMoa067731. Epub 2007 Feb 12.
9
Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials.药物洗脱支架的晚期血栓形成:随机临床试验的荟萃分析
Am J Med. 2006 Dec;119(12):1056-61. doi: 10.1016/j.amjmed.2006.01.023.
10
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.急性心肌梗死后使用选择性环氧化酶-2抑制剂和非选择性非甾体抗炎药相关的死亡或再梗死风险。
Circulation. 2006 Jun 27;113(25):2906-13. doi: 10.1161/CIRCULATIONAHA.106.616219. Epub 2006 Jun 19.